ConductScience.org, home

Library / Genes

RAD51: RAD51 recombinase

1 protein, 102 patents, 0 drugs, 0 trials, 7,181 NIH grants and 18,452 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolRAD51HGNC
NameRAD51 recombinaseHGNC
NCBI Gene ID5888NCBI Gene
HGNC IDHGNC:9817HGNC
EnsemblENSG00000051180NCBI Gene
AliasesBRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECANCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q06609DNA repair protein RAD51 homolog 133952Ensembl, GeneID, HGNCUniProt

Patents 102

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-192632Q06609Espacenet
EP 4641202 A22025-10-294616Q06609Espacenet
WO 2025137408 A12025-06-26123Q06609Espacenet
JP 2025517970 A2025-06-122632Q06609Espacenet
WO 2025101994 A22025-05-151570Q06609Espacenet
US 12258591 B22025-03-2558Q06609Espacenet
US 12252717 B22025-03-18149Q06609Espacenet
KR 1020250017231 A2025-02-044616Q06609Espacenet
US 12214008 B22025-02-0482Q06609Espacenet
JP 2025500399 A2025-01-0948Q06609Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 7181

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant1582,025NIH's project files
P30CA008748Cancer Center Support Grant1572,025NIH's project files
P01CA092584Structural Cell Biology of DNA Repair Machines1472,025NIH's project files
R01ES007061Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice662,025NIH's project files
R01GM058015Recombinational Mechanisms of DNA Repair422,025NIH's project files
ZIAAG000741Roles Of DNA Helicases In Pathways Required For Maintenance Of Genomic Stability372,025NIH's project files
R35GM118026Mechanisms of Genome Integrity342,025NIH's project files
P30CA047904Cancer Center Support Grant332,025NIH's project files
P30CA054174Mays Cancer Center at UT Health SA312,025NIH's project files
P30CA086862Cancer Center Support Grant312,025NIH's project files

Papers 18452

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827478PubTator, text miningPubMed
42823448PubTator, text miningPubMed
42822289PubTator, text miningPubMed
42817804PubTator, text miningPubMed
42809932PubTator, text miningPubMed
42809925PubTator, text miningPubMed
42794557PubTator, text miningPubMed
42794475PubTator, text miningPubMed
42792682PubTator, text miningPubMed
42790317PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license